Top

Metabolic Brain Disease

Published in:

26-09-2023 | Retraction Note

Retraction Note: Chronic and progressive dopaminergic neuronal death in substantia nigra associates with a decrease in serum levels of glucose and free fatty acids, the role of interlokin-1 beta

Authors: Ali Sarbazi-Golezari, Hashem Haghdoost-Yazdi

Published in: Metabolic Brain Disease | Issue 3/2024

Excerpt

Retraction Note: Metabolic Brain Disease (2021) 37:373–381 …

Sophiabadi M, Rastgoo N, Haghdoost-Yazdi H (2022) Dopaminergic neuronal death in Substantia Nigra associates with serum levels of total bilirubin, selenium, and zinc: evidences from 6-hydroxydopamine animal model of parkinson’s disease. Biol Trace Elem Res 200:4058–4067. https://doi.org/10.1007/s12011-021-03012-6CrossRefPubMed

Title: Retraction Note: Chronic and progressive dopaminergic neuronal death in substantia nigra associates with a decrease in serum levels of glucose and free fatty acids, the role of interlokin-1 beta
Authors: Ali Sarbazi-Golezari
Hashem Haghdoost-Yazdi
Publication date: 26-09-2023
Publisher: Springer US
Published in: Metabolic Brain Disease / Issue 3/2024
Print ISSN: 0885-7490
Electronic ISSN: 1573-7365
DOI: https://doi.org/10.1007/s11011-023-01298-0

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Retraction Note: Chronic and progressive dopaminergic neuronal death in substantia nigra associates with a decrease in serum levels of glucose and free fatty acids, the role of interlokin-1 beta

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 3/2024

The role of astrocytes in the glymphatic network: a narrative review

Circ_0027446 promotes malignant development of glioblastoma by interacting with miR-346 to up-regulate PGK1

Lessons on brain edema in HE: from cellular to animal models and clinical studies

Sestrin2 can alleviate endoplasmic reticulum stress to improve traumatic brain injury by activating AMPK/mTORC1 signaling pathway

Development of novel treatments for amyotrophic lateral sclerosis

Exploring sulforaphane as neurotherapeutic: targeting Nrf2-Keap & Nf-Kb pathway crosstalk in ASD